(Q71574682)
Statements
Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease (English)
A B Thomson
J P Wright
R J Bailey
D Rachmilewitz
M Adler
K A Wilson-Lynch
1 December 1995